Board of Directors

John J. Connolly, Ed.D., Chairman of Board

Dr. Connolly is the President and Chief Executive Officer of Castle Connolly Medical. He assumed that position in 1992 after serving as President and Chief Executive Officer of New York Medical College for over ten years. Dr. Connolly has been extensively involved in healthcare and the biomedical sciences for over two decades. He is a Fellow of the New York Academy of Medicine and a member of the New York Academy of Science. He serves on the President's Advisory Council of the United Hospital Fund, as a Director of the New York Business Group on Health and on the Board of Associates of the Whitehead Institute for Biomedical Science. He also served as the Chairman of the Board of Trustees of St. Francis Hospital in Poughkeepsie, New York.

Dr. Connolly is presently a member of the Commission on Biomedical Research at the New York Academy of Medicine and is a director, and past Chairman, of the American Lyme Disease Foundation. Dr. Connolly presently serves as a Director of Mortons Restaurant Group, Charley Browns Holdings, Health Enhancement, Inc., and Dearborn Risk Management, Inc.

K. Michael Forrest, Director

Mr. Forrest is currently President and CEO of Cellegy Pharmaceuticals, Inc. a biopharmaceutical company that specializes in the development and marketing of specialty products in the areas of gastroenterology, sexual dysfunction and women’s health care. He has recently served as President and Chief Executive Officer of Mercator Genetics, a venture capital backed genomics company focused on positional cloning of monogenic and polygenic disease genes. He has over 30 years experience in leading pharmaceutical and biotechnology companies.

Mr. Forrest has worked for Pfizer, Inc. and the American Cyanamid Company in a variety of senior management positions in domestic and overseas markets. Mr. Forrest has also served as President and CEO of Transkaryotic Therapies, Inc. a gene activation and ex-vivo gene therapy company located in Cambridge, MA. He is a director of Inex Pharmaceuticals, a company which focuses on the development of novel cancer therapeutics.

Steven Hochberg, Director

Mr. Hochberg is a partner and managing director of ProMed Management, a private investment group involved in significant healthcare and biomedical financings. He was co-founder of Advanced Health Corporation, a publicly traded physician practice management and clinical information systems company. He also co-founded Physicians' Online, a provider of interactive medical reference and communications services to over 150,000 physicians. Recently, he has been active as lead investor in several venture capital backed healthcare and technology companies. Mr. Hochberg is also Chairman of the Board of Digital Chef, the leading website for food related interests.

Donald J. McCarren, Ph.D., Director

Dr. McCarren became President, Chief Executive Officer, and Board member on August 24, 1998. He has spent more than three decades in the health care industry.

During this time, he has held positions of increasing responsibility with several major pharmaceutical companies; Warner Lambert, Merck, Pfizer, Abbott and Erbamont (now owned by Pharmacia-Upjohn). In addition, he founded a smart polymer drug delivery company, Tacora, and served as President of Immunogen, a molecule drug discovery company targeting cancer. Most recently, he was President and CEO of the National Center for Genome Resources. Dr. McCarren has a broad range of experience in both the international and domestic markets.